hero section gradient
13 handpicked stocks

Market Greed

Ride the wave of investor optimism with this carefully selected group of high-growth companies. Our professional analysts have identified businesses positioned to deliver amplified returns when market sentiment is bullish and risk appetite is high.

Author avatar

Han Tan | Market Analyst

Published on June 18

Your Basket's Financial Footprint

Summary and key takeaways for investors based on basket market capitalisation.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and closer tracking of broad market movements, versus small-cap baskets.
  • Use as a core, long-term portfolio holding for stabilising allocation, not as a speculative or high-growth trade.
  • Expect steady, long-term capital appreciation rather than explosive short-term gains; returns are likely moderate and gradual.
Total Market Cap
  • TSLA: $1.47T

  • COIN: $87.00B

  • MSTR: $86.68B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection targets companies built for aggressive expansion during periods of intense market optimism. These stocks typically outperform when investor confidence is high and economic growth is strong. They represent businesses at the forefront of innovation, even if they're not yet consistently profitable.

2

What You Need to Know

These stocks tend to be more volatile than the broader market, offering higher potential returns with increased risk. They're particularly sensitive to interest rate changes, with falling rates creating a favorable environment. Consider these as tactical, aggressive additions to a well-balanced portfolio.

3

Why These Stocks

Our analysts selected these companies based on their high sensitivity to positive market sentiment and economic upswings. They feature businesses pioneering disruptive technologies across sectors like electric vehicles, cryptocurrency, fintech, and biotechnology—all with potential for explosive, non-linear growth.

Why You'll Want to Watch These Stocks

🚀

Riding the Bull Wave

These stocks are positioned to potentially deliver outsized returns when market sentiment turns bullish and investors are ready to take on more risk. Don't miss the upswing.

💡

Tomorrow's Winners Today

This collection features innovative disruptors at the cutting edge of technology, finance, and transportation—companies pioneering industries that could define our future.

🔍

Rate Cut Beneficiaries

With interest rates expected to fall, these growth-oriented companies could see significant valuation boosts as their future earnings become more valuable in today's terms.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions